WHO approves China's Sinopharm vaccine in potential boost to

WHO approves China's Sinopharm vaccine in potential boost to COVAX pipeline


WHO approves China's Sinopharm vaccine in potential boost to COVAX pipeline
Today
12:00 pm JST
Today | 12:23 pm JST
GENEVA
The World Health Organization(WHO) approved for emergency use a COVID-19 vaccine from China's state-owned drugmaker Sinopharm on Friday, bolstering Beijing's push for a bigger role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.
It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects.

Related Keywords

Beijing , China , United States , Chinese , America , Bruce Aylward , Arnaud Didierlaurent , Tedros Adhanom Ghebreyesus , Alejandro Craviato , Sinovac Biotech , World Health Organization , Pfizer , China National Biotec Group , Astrazeneca , Products Institute , Johnson , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , பெய்ஜிங் , சீனா , ஒன்றுபட்டது மாநிலங்களில் , சீன , அமெரிக்கா , காயங்கள் ஐலவ்ர்டு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஃபைசர் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , ஜான்சன் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

© 2025 Vimarsana